Robert J. Canter

University Of California At Davis

$2,289,473

Attributed

$4,893,243

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY2017–24

$2M$1.5M$1M$500K$0

'17

'18

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$4,893,243 · 4

By mechanism

U01$2,968,295 · 1

T32$1,616,911 · 1

R03$308,037 · 2

Top collaborators

Most similar at University Of California At Davis

Same institution · by research overlap

Kit S Lam$32,497,491
Abhijit J Chaudhari$6,113,266
Luke A. Wittenburg$898,536
Robert B Rebhun$3,820,525
Danika L Bannasch$3,249,648

Others in their field

Other Emerging Leaders on “Immunotherapy”

Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,653,178
Leonard Freedman · Leidos Biomedical Research, Inc.$66,640,671
Leonard Freedmand · Leidos Biomedical Research, Inc.$54,755,085
Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$28,983,611

Research focus

ImmunotherapyMalignant NeoplasmsCanis FamiliarisNatural Killer CellsImmuneTranslationsResponseInterleukin-15TumorComparativeToxic EffectCytokineAdoptive TransferMetastatic OsteosarcomaInhalationCancer TherapyOsteosarcomaMouse ModelMediatingImmune SystemClinical TrialsCellsBiologicalGene Expression